(Reuters) AstraZeneca sold its stake in rival COVID-19 vaccine maker Moderna for roughly $1 billion over the course of last year as the Anglo-Swedish drugmaker cashed in on the meteoric rise in the U.S. company’s shares.
AstraZeneca sells stake in vaccine maker Moderna for nearly $1 billion
This entry was posted in Syndicated. Bookmark the permalink.
